Treating Delusional Disorder: A Comparison of Cognitive-Behavioural Therapy and Attention Placebo Control | Zendy

Kieron O’Connor | Zendy; Émmanuel Stip | Zendy; MarieClaude Pélissier | Zendy; Frederick Aardema | Zendy; Stéphane Guay | Zendy; Gilles Gaudette | Zendy; Ian van Haaster | Zendy; Sophie Robillard | Zendy; Sébastien Grenier | Zendy; Yves Careau | Zendy; P Doucet | Zendy; Vicky Leblanc | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treating Delusional Disorder: A Comparison of Cognitive-Behavioural Therapy and Attention Placebo Control

Author(s) -

Kieron O’Connor,

Émmanuel Stip,

MarieClaude Pélissier,

Frederick Aardema,

Stéphane Guay,

Gilles Gaudette,

Ian van Haaster,

Sophie Robillard,

Sébastien Grenier,

Yves Careau,

P Doucet,

Vicky Leblanc

Publication year - 2007

Publication title -

the canadian journal of psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.68

H-Index - 117

eISSN - 1497-0015

pISSN - 0706-7437

DOI - 10.1177/070674370705200310

Subject(s) - psychology , delusion , schizophrenia (object oriented programming) , conviction , affect (linguistics) , cognition , placebo , clinical psychology , psychiatry , psychotherapist , medicine , alternative medicine , communication , pathology , political science , law

Cognitive-behavioural therapy (CBT) has proved effective in treating delusions, both in schizophrenia and delusional disorder (DD). Clinical trials of DD have mostly compared CBT with either treatment as usual, no treatment, or a wait-list control. This current study aimed to assess patients with DD who received CBT, compared with an attention placebo control (APC) group.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research